Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
|
US |
|
S
|
SSE PLC
XMUN:SCT
|
UK |
|
R
|
Rio Tinto PLC
OTC:RTPPF
|
UK |
|
M
|
Mitsubishi Chemical Holdings Corp
F:M3C
|
JP |
|
W
|
Wesco International Inc
F:WP7
|
US |
|
A
|
Abercrombie & Fitch Co
XMUN:AFT
|
US |
|
E
|
Eni SpA
XMUN:ENI
|
IT |
|
National Bankshares Inc
F:9F2
|
US |
|
TE Connectivity PLC
F:BZ4
|
IE |
|
B
|
Barito Renewables Energy PT Tbk
IDX:BREN
|
ID |
|
S
|
Suncor Energy Inc
NYSE:SU
|
CA |
|
electroCore, Inc.
NASDAQ:ECOR
|
US |
|
D
|
DS Smith PLC
OTC:DITHF
|
UK |
|
B
|
BAE Systems PLC
DUS:BSP
|
UK |
|
T
|
Travelers Companies Inc
F:PA9
|
US |
|
C
|
Cadence Design Systems Inc
XBER:CDS
|
US |
|
P
|
Papa John's International Inc
F:PP1
|
US |
Bankruptcy Probability
Amylyx Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Amylyx Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
|
2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
643.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
318.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
222.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
238.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
296.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Amylyx Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Amylyx Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.
